US Senator raises alarm over poor-quality drug imports from India and China, seeks tougher FDA inspections

US Senator raises alarm over poor-quality drug imports from India and China, seeks tougher FDA inspections

US Senator Jim Banks has urged the Food and Drug Administration (FDA) to step up inspections of overseas pharmaceutical manufacturing facilities, expressing concern over poor-quality drugs being imported from countries like India and China. In a letter to FDA Commissioner Martin Makary, Banks said the agency must “do more to protect the US drug supply,”…

Read More